Phase 1b study of WNT inhibitor vantictumab (VAN, human...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC)

Messersmith, W., Cohen, S., Shahda, S., Lenz, H-J., Weekes, C., Dotan, E., Denlinger, C., O'Neil, B., Kapoun, A., Zhang, C., Henner, R., Cattaruzza, F., Xu, L., Dupont, J., Brachmann, R., Uttamsingh,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw371.69
Date:
October, 2016
File:
PDF, 41 KB
english, 2016
Conversion to is in progress
Conversion to is failed